Pluvicto, Novartis’ blockbuster radiopharmaceutical for prostate cancer, has been greenlighted by the FDA for use earlier in ...

PTC Therapeutics' Translarna loses EU conditional approval, but countries may allow continued use. PTC submitted four FDA ...

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the European Commission (EC) has adopted the opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...

PTC Therapeutics said on Friday the European Commission will remove its inherited progressive muscle-wasting disorder from the region after an advisory panel reaffirmed a negative opinion of the drug ...

Learn more about whether Alvotech or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which ...

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald initiated coverage with a Buy rating on Soleno Therapeutics (SLNO – ...

PTC Inc. is expanding with cloud-native tools and AI integration. Learn why PTC stock is a solid "Buy" on dips, driven by ...

The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary ...

PTC Therapeutics, Inc. today shared new data being presented from the Phase 3 APHENITY trial and subsequent open-label extension study at the 2025 American College of Medical Genetics and Genomics ...

The stock market is expected to remain directionless next week, but experts have identified eight stocks that could ...

Benchmark stock indices opened the week on a positive trajectory, bringing much-needed relief to Dalal Street investors. The ...

Learn more about whether PTC Therapeutics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...